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Neudesin was originally identified as a secreted protein with neurotrophic activity, and,
thereafter, was also termed neuron-derived neurotrophic factor (NENF) or the candidate
oncogene GIG47. Neudesin with a conserved cytochrome 5-like heme/steroid-binding
domain activates intracellular signaling pathways possibly through the activation of G
protein-coupled receptors. In the brain, hypothalamic Neudesin decreases food intake.
Neudesin knockout (KO) mice also exhibit anxiety-like behavior, indicating its roles in the
hippocampal anxiety circuitry. Neudesin is also expressed in various peripheral tissues.
Neudesin KO mice are strongly resistant to high-fat diet (HFD)-induced obesity due
to elevated systemic sympathetic activity, heat production, and adipocytic lipolysis.
Neudesin, which is over-expressed or induced by DNA hypomethylation in multiple
human cancers, also stimulates tumorigenesis. These findings indicate that Neudesin
plays roles in neural functions, energy metabolism, and tumorigenesis and is expected
to be a novel target for obesity and anti-cancer treatments.
Keywords: anxiety, membrane-associated progesterone receptor, metabolism, neudesin, neuron-derived
neurotrophic factor, obesity, tumorigenesis
Introduction
Neudesin was originally identified as a secreted protein with neurotrophic activity from mouse
embryos (Kimura et al., 2005). Thereafter, it was also termed NENF and GIG47 (Han et al., 2012;
Byerly et al., 2013). Human Neudesin is a secreted protein of 172 amino acids with a conserved
cytochrome 5-like heme/steroid-binding domain of ∼100 amino acids (Figure 1A) (Kimura
et al., 2005, 2008). Neudesin is a member of the membrane-associated progesterone receptor
(MAPR) protein family comprising three additional members with characteristic cytochrome
5-like heme/steroid-binding domains: progesterone receptor-membrane component (PGRMC1),
PGRMC2, and Neuferricin (Figure 1B) (Ohta and Itoh, 2012; Kimura et al., 2013).
PGRMC1 was originally identified as a putative receptor for progesterone (Meyer et al.,
1996). However, PGRMC1 binds heme, not progesterone (Cahill, 2007). PGRMC1 and PGRMC2
are mainly located in the endoplasmic reticulum (Gerdes et al., 1998; Chen et al., 2010). The
expression of PGRMC1 is up-regulated in cancer cells. PGRMC1 promotes cell survival and damage
resistance in cancer cells and also plays roles in lipid, drug, and hormone metabolism in the
liver and neuroprotection in the brain. PGRMC2 is also expressed in breast adenocarcinoma
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FIGURE 1 | Amino acid sequence of human Neudesin (A) and
comparison of heme/steroid-binding domains in the human MAPR
family (B). (A) Underlines indicate a cleavable secreted signal sequence
and conserved heme/steroid-binding domain. Asterisks indicate the two
conserved tyrosine residues, 82 and 88, which are essential for
heme-binding. The numbers refer to amino acid positions. (B) Dashes
indicate gaps introduced to align sequences. Asterisks indicate identical
amino acid residues in sequences. Underlines indicate the two
conserved tyrosine residues essential for heme-binding in the MAPR
family.
(Rohe et al., 2009; Intlekofer and Petersen, 2011). In contrast,
Neuferricin is a secreted protein that promotes neurogenesis in
neural precursor cells and suppresses cell survival in Neuro2a
cells (Kimura et al., 2010). Neuferricin also enhances the survival
of ectoside-exposed cells, cytochrome P450 activities, and the
growth and survival of HeLa cells (Xie et al., 2011; Bruce and
Rybak, 2014).
PGRMC1 and PGRMC2 have two conserved introns,
indicating that they were generated from a common ancestral
gene. In contrast, Neudesin has non-conserved introns. Thus,
Neudesin is not evolutionarily related to the other members
of the MAPR family (Ohta and Itoh, 2012). The roles and
action mechanism of Neudesin are also distinct from those of
the other members. Neudesin plays roles as a multi-functional
secreted protein in neural functions, energy metabolism, and
tumorigenesis. In this review, we focused on multi-functional
Neudesin with recent findings.
Structure
The amino acid sequence of Neudesin is highly conserved in
vertebrates (Ohta and Itoh, 2012). A nuclear magnetic resonance
analysis indicated that Neudesin, which is also termedGIG47, has
an α-helice/β-strand structure with a β1-α1-β2-β3-α2-β4-α3-α4-
β5-β6 topology. The heme/steroid-binding domain is located in
the α2-β4-α3 topology. A homology modeling calculation with
the known tertiary structure of 1TOG, a hypothetical protein
of unknown function with a cytochrome b5-like fold, indicated
the tertiary structure of Neudesin. A potential heme/steroid-
binding hydrophobic pocket is visible between the α2 and α3
helices. Tyrosine residues 82 and 88 in this pocket are essential
for heme-binding (Han et al., 2012).
Activity and Action Mechanism of
Neudesin
Neudesin is preferentially expressed in the brain and spinal
cord at embryonic stages in mice, but is widely expressed
in various tissues including the brain, adipose tissue, heart,
lung, and kidney at postnatal stages. In the brain, Neudesin is
preferentially expressed in neurons. Neudesin exhibits significant
neurotrophic activity in primary cultured neurons, but not
mitogenic activity in primary cultured astrocytes, indicating that
it is a neurotrophic factor. The conserved cytochrome 5-like
heme/steroid-binding domain of Neudesin has been shown to
bind heme and is required for its activity (Kimura et al., 2005,
2008). Neudesin activates the mitogen-activated protein kinase
(MAPK) and phosphatidylinositol-3 kinase (PI3K) pathways.
The phosphorylation of extracellular signal-regulated kinase
(ERK)1/2 by Neudesin is inhibited by the pertussis toxin (PTX),
an inhibitor of the Gi/Go-protein, indicating that its activity is
mediated via activation of the MAP and PI3K pathways, which
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are potentially coupled with the Gi/Go-protein-coupled signaling
pathway (Kimura et al., 2005) (Table 1).
Neudesin is also expressed in neural precursor cells before the
appearance of neurons in mice, indicating its potential roles in
neural development (Kimura et al., 2006). Neudesin significantly
promotes neuronal differentiation that is mediated though
activation of the protein kinase A (PKA) and PI3K pathways
in cultured neural precursor cells. It also transiently promotes
neural cell proliferation early in the developmental process. This
proliferation is mediated through the MAPK and PKA pathways.
The expression profile and activity of Neudesin indicate that
it plays unique roles in neural cell proliferation and neuronal
differentiation (Kimura et al., 2006). The phosphorylation of
ERK, serine-threonine protein kinase AKT, and cAMP response
element binding protein (CREB) is also promoted by Neudesin
in neural precursor cells. However, its action is not inhibited
by PTX. Neudesin increases cAMP levels in neural precursor
cells, indicating that its activity is potentially exerted via the
Gs protein-coupled signaling pathway and that the mechanism
of action of neudesin in these cells is distinct from that in
the neurons (Kimura et al., 2006). Neudesin is also abundantly
expressed in cultured mouse neuroblastoma Neuro2a cells. Cell
survival and proliferation are significantly decreased in Neuro2a
cells by the siRNA-mediated knockdown of Neudesin (Kimura
et al., 2008). Neudesin activates the MAPK and PI3K signaling
pathways in cultured adipocytes and cancer cells (Kimura et al.,
2009; Han et al., 2012) (Table 1).
Hemin significantly promotes the activity of Neudesin in
primary cultured cells, indicating that the heme-binding domain
is essential for its activity (Cahill, 2007). As Neudesin is a secreted
protein, it is expected to exert its activity by binding to and
activating its specific cell surface receptor. Since the activity of
Neudesin is exerted via the G protein-coupled signaling pathway,
its receptor is expected to be a G protein-coupled receptor
(GPCR). Although currently unknown, the identification of
Neudesin receptors will provide an important insight into the
action mechanism of Neudesin.
Roles of Neudesin in Neuronal Functions
Neudesin exhibits neurotropic activity in cultured neuronal cells,
therefore, it is assumed to play in vivo roles in neuronal functions.
Some secreted proteins in the brain including brain-derived
neurotrophic factor (BDNF), ciliary neurotrophic factor, and
neuropeptide Y can regulate energy uptake and expenditure
(Fargali et al., 2012). Neudesin was also identified through large-
scale screening aimed at identifying novel secreted hypothalamic
proteins that regulate food intake (Byerly et al., 2013). Neudesin
is strongly expressed in hypothalamic nuclei that regulate food
intake. BDNF in the hypothalamus is an important regulator
of appetite. The expression of Neudesin in the hypothalamus
is decreased by the administration of BDNF into the lateral
cerebral ventricle. The administration of Neudesin into the
cerebral ventricle resulted in decreases in food intake and body
weight and increases in the expression of pro-opiomelanocortin
and melanocortin 4 receptor in the hypothalamus. However, the
effects of Neudesin on food intake is abrogated in obese mice fed
a high-fat diet (HFD), indicating the diet-dependent modulation
of Neudesin functions. These findings indicate that hypothalamic
Neudesin is a potential central modulator of food intake via
TABLE 1 | Activity and roles of Neudesin in neural functions, energy metabolism, and tumorigenesis.
Neudesin gain-of-function Loss-of-function Action site References
NEURAL FUNCTIONS
Neurotrophic activity Cultured neuronal cells Kimura et al., 2005
Differentiation activity Cultured neural precursor cells
Cell proliferation activity Cultured neural precursor cells Kimura et al., 2006
Inhibition of cell proliferation/survival Cultured Neuro2a cells Kimura et al., 2008
Decreased food intake Mice Byerly et al., 2013
Anxious-like behavior Mice Ohta et al., 2015
ENERGY METABOLISM
Inhibition of adipogenesis Cultured 3T3-L1 cells Kimura et al., 2009
Promotion of adipogenesis Cultured 3T3-L1 cells Kimura et al., 2009
Resistance to HFD-induced obesity/metabolic dysfunction Mice Ohta et al., 2015
Increased sympathetic activity Mice Ohta et al., 2015
Increased energy expenditure Mice Ohta et al., 2015
Increased heat production/fatty acid oxidation in BAT Mice Ohta et al., 2015
Increased lipolysis in WAT Mice Ohta et al., 2015
TUMORIGENESIS
Invasiveness activity Cultured MCF cells Han et al., 2012
Tumorigenicity Cultured MCF cells Han et al., 2012
Inhibition of cell growth Cultured cancer cells Stefanska et al., 2014
Inhibition of invasiveness Cultured cancer cells Stefanska et al., 2014
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a regulatory circuit that may involve BDNF and melanocortin
signaling (Byerly et al., 2013) (Table 1).
Neudesin knockout (KO) mice appear to be normal and fertile
(Novais et al., 2013; Ohta et al., 2015). An extensive behavioral
characterization (motor, emotional, and cognitive dimensions) of
Neudesin KO mice revealed anxiety-like behavior. In association
with the anxious phenotype, dopaminergic input was reduced
and dendritic arborization was impoverished in dentate gyrus
granule neurons in the ventral hippocampus. Shorter dendrites
were also observed in the bed nucleus of the stria terminalis.
These findings suggest the roles of Neudesin in maintaining the
hippocampal anxiety circuitry (Novais et al., 2013) (Table 1).
Roles of Neudesin in Energy Metabolism
White adipose tissue (WAT) is crucially involved in energy
metabolism. Obesity, which is characterized by the excessive
development of WAT, is a risk factor for several metabolic
diseases, including type II diabetes, hypertension, and
atherosclerosis. The development of WAT involves adipogenesis
and an increase in the number of cells (Hausman et al., 2001).
Neudesin is also abundantly expressed in the WAT of mice. It has
been shown to significantly suppress adipogenesis in cultured
3T3-L1 preadipocytes. The knockdown of Neudesin by RNA
interference markedly promoted adipogenesis by suppressing
activation of the MAPK pathway activation in 3T3-L1 cells.
These findings suggest that Neudesin may be a negative regulator
in the early stage of adipogenesis (Kimura et al., 2009) (Table 1).
Neudesin KO mice are strongly resistant to HFD-induced
obesity and metabolic dysfunction. However, food intake is
essentially unaffected in Neudesin KOmice fed HFD (Ohta et al.,
2015). Thus, resistance to HFD-induced obesity is independent
of food intake. As discussed above, the administration of
Neudesin decreased food intake (Byerly et al., 2013). This
discrepancy may be explained by differences in physiological
analyses using Neudesin KO mice and pharmacological analyses
by the administration of recombinant Neudesin.
Adipose tissue consists of two distinct types: white and
brown. WAT stores excess energy as triglycerides. In contrast,
brown adipose tissue (BAT) dissipates energy as heat, thereby
counteracting obesity (Frontini and Cinti, 2010; Cristancho and
Lazar, 2011). The sympathetic nervous system (SNS) plays crucial
roles in maintaining energy homeostasis. The activated SNS
stimulates lipolysis in WAT and enhances heat production in
BAT by activating adrenergic signaling. Thus, the SNS is essential
for regulating adipose function and the development of obesity
(Tentolouris et al., 2006). Sympathetic activity was found to be
significantly increased in Neudesin KO mice fed HFD, resulting
in increased energy expenditure and heat production as well as
fatty acid oxidation in BAT and enhanced lipolysis inWAT (Ohta
et al., 2015) (Table 1). These findings indicate that Neudesin
is a negative regulator of energy expenditure and could be an
attractive target for the development of anti-obesity drugs.
Roles of Neudesin in Tumorigenesis
Neudesin has also been identified as GIG47 using a differential
display technique to discover genes critical for breast
tumorigenesis (Han et al., 2012). Neudesin is over-expressed
in multiple human cancers including carcinomas of the breast,
uterine cervix, malignant lymphoma, colon, lung, and skin as
well as in leukemia and breast cancer cell line MCF-7. The
ectopic expression of Neudesin in MCF7 cells has been shown
to promote invasiveness in vitro and increase tumorigenicity
in vivo. The mechanism underlying tumorigenesis may be
mediated by activation of the MAPK and PI3K pathways. These
findings indicate that Neudesin is involved in tumorigenesis
and may be a novel target for the treatment of cancers
(Table 1).
Common hypomethylated genes in many cancers are
candidates for novel broad-spectrum anti-cancer and anti-
metastatic agents. Whole-genome mapping has identified
many activated gene promoters by DNA hypomethylation in
hepatocellular carcinoma (HCC) clinical samples. Neudesin is
also hypomethylated and induced inHCC (Stefanska et al., 2014).
The ineffectiveness of Neudesin mediated by RNA interference
in different types of cancers effectively and specifically inhibited
their cell growth and invasive capacities. This ineffectiveness
was also found to reduce their growth as explants in mice
and interfere with the AKT, WNT, and MAPK signaling
pathways. These findings indicate that Neudesin is induced
by hypomethylation in many cancers and is a candidate
target for anti-cancer therapeutics in multiple cancer cell types
(Table 1).
Conclusions
Neudesin, which is a member of the MAPR family, is a
unique secreted protein with a conserved cytochrome 5-like
heme/steroid-binding domain and plays multi-functional roles
in neural functions, energy metabolism, and tumorigenesis. In
the brain, Neudesin may be a neurotrophic factor in food
intake in the hypothalamus and in maintaining the hippocampal
anxiety circuitry. Neudesin KO mice are strongly resistant to
HFD-induced obesity, indicating that Neudesin is a negative
regulator of energy expenditure in peripheral tissues. Neudesin
is also expressed in multiple human cancers and stimulates
tumorigenesis. Further studies on Neudesin will provide useful
clues for the development of treatments for metabolic diseases
and cancers.
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